Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3775853
Max Phase: Preclinical
Molecular Formula: C26H29N3O7S
Molecular Weight: 527.60
Molecule Type: Small molecule
Associated Items:
ID: ALA3775853
Max Phase: Preclinical
Molecular Formula: C26H29N3O7S
Molecular Weight: 527.60
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCOc1cccc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1
Standard InChI: InChI=1S/C26H29N3O7S/c1-6-12-35-17-8-7-9-18(13-17)36-24-16-22-21(28(2)26(30)29(22)3)15-20(24)27-37(31,32)19-10-11-23(33-4)25(14-19)34-5/h7-11,13-16,27H,6,12H2,1-5H3
Standard InChI Key: DYNNLYLIKZTWRT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 527.60 | Molecular Weight (Monoisotopic): 527.1726 | AlogP: 4.28 | #Rotatable Bonds: 10 |
Polar Surface Area: 110.02 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 6.99 | CX Basic pKa: | CX LogP: 3.63 | CX LogD: 3.19 |
Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.33 | Np Likeness Score: -1.16 |
1. Palmer WS, Poncet-Montange G, Liu G, Petrocchi A, Reyna N, Subramanian G, Theroff J, Yau A, Kost-Alimova M, Bardenhagen JP, Leo E, Shepard HE, Tieu TN, Shi X, Zhan Y, Zhao S, Barton MC, Draetta G, Toniatti C, Jones P, Geck Do M, Andersen JN.. (2016) Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor., 59 (4): [PMID:26061247] [10.1021/acs.jmedchem.5b00405] |
2. Yan J, Li T, Miao Z, Wang P, Sheng C, Zhuang C.. (2022) Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation., 65 (13.0): [PMID:35763424] [10.1021/acs.jmedchem.2c00728] |
3. Tomaselli D, Mautone N, Mai A, Rotili D.. (2020) Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)., 207 [PMID:32871345] [10.1016/j.ejmech.2020.112750] |
Source(1):